Key statistics
On Monday, Glaukos Corp (6GJ:FRA) closed at 100.00, -12.28% below its 52-week high of 114.00, set on Mar 03, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 100.00 |
|---|---|
| High | 100.00 |
| Low | 100.00 |
| Bid | -- |
| Offer | -- |
| Previous close | 101.00 |
| Average volume | 14.00 |
|---|---|
| Shares outstanding | 58.08m |
| Free float | 55.78m |
| P/E (TTM) | -- |
| Market cap | 6.99bn USD |
| EPS (TTM) | -3.27 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:26 GMT.
More ▼
Press releases
- Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
- Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
- Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
- Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
- Glaukos Announces Participation in J.P. Morgan Healthcare Conference
More ▼
